## Abstract CCR5 inhibitors remain an attractive antiretroviral treatment option for HIV‐infected patients; however, tropism testing should be utilized prior their introduction. This study analyzed genotypic HIV‐1 tropisms in patients with evidence of genotypic drug resistance to antiretroviral the
Electronic Transduction of HIV-1 Drug Resistance in AIDS Patients
✍ Scribed by Lital Alfonta; Immanuel Blumenzweig; Maya Zayats; Lea Baraz; Moshe Kotler; Itamar Willner
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 181 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1439-4227
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Transmitted drug resistance (TDR) is a concern because it may reduce the efficacy of antiretroviral treatment. Plasma samples of 119 HIV‐1‐infected patients who were newly diagnosed at the Infectology Center of Latvia in 2005 and 2006 were analyzed by an in‐house genotypic resistance as
## Abstract This study reports the analysis of human immunodeficiency virus type 1 (HIV‐1) protease (PR) and reverse transcriptase (RT) coding sequences from 136 HIV‐1‐infected subjects from Chile, 66 (49%) of them under antiretroviral (ARV) treatment. The prevalence of mutations conferring high or
## Abstract Genotyping for HIV drug resistance is costly and beyond the means for many Southeast Asian patients, who are self‐funded. This prompted the development of a more cost‐effective, in‐house assay for an ethnically diverse, Southeast Asian population at the National University Hospital in S
Peripheral blood mononuclear cells from HIV-1 -infected persons were mixed with 5 M guanidine thiocyanate, and HIV-1 -specific probes were hybridized with target RNA directly in the lysate. No RNA purification was needed. Hybrids were purified by repeated capture on superparamagnetic beads coated
To study the distribution of HIV types and genotypes, in Lome ´, Togo, a random population of patients who met the clinical criteria of the Bangui definition of AIDS and were positive with two independent screening assays for antibodies to HIV-1 group M, HIV-2, and HIV-1 group O was selected. HIV RN